HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
Beauty FDA Leadership

Gottlieb Leaves FDA With Final Thought On What To Do About Cosmetics

  • News

Executive Summary

Addressing for the last time the House Appropriations subcommittee with FDA oversight, Commissioner Scott Gottlieb shared his vision for sharpening cosmetics oversight in the absence of significant new resources.

Table

View full table

Advertisement

Related Content

HBW Insight
ICMAD: Federal Cosmetics Legislation Without National Uniformity Not In Industry’s Interest
Pink Sheet
Gottlieb's Parting Words For US FDA: 'Be Willing To Push' For Major Policy Changes
Pink Sheet
Gottlieb Unleashed: Focus on Drug Pricing To Intensify As He Rejoins AEI
Medtech Insight
Departing FDA Head Gottlieb Advises Successor Sharpless To Heed Center Directors, Defends Budget To Congress
HBW Insight
Cosmetics ‘Are Not Risk-Free’; FDA Committed to Modernizing Regs – Commish Gottlieb

Topics

Advertisement
Tags:
Beauty FDA Leadership
UsernamePublicRestriction

Register

RS148717

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By